Lifevantage Corporation (NASDAQ:LFVN - Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $5.76 and traded as high as $6.69. Lifevantage shares last traded at $6.57, with a volume of 44,291 shares changing hands.
Analyst Ratings Changes
A number of brokerages have recently issued reports on LFVN. Lake Street Capital downgraded Lifevantage from a "buy" rating to a "hold" rating and set a $5.00 price objective on the stock. in a research note on Thursday, May 7th. Weiss Ratings raised Lifevantage from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, May 26th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $5.00.
View Our Latest Analysis on Lifevantage
Lifevantage Price Performance
The firm has a market capitalization of $82.91 million, a price-to-earnings ratio of 14.60 and a beta of 0.72. The business's fifty day simple moving average is $6.70 and its 200 day simple moving average is $5.76.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. New York State Common Retirement Fund acquired a new position in shares of Lifevantage during the second quarter worth approximately $102,000. Cubist Systematic Strategies LLC acquired a new position in Lifevantage during the first quarter worth $97,000. Wells Fargo & Company MN lifted its stake in shares of Lifevantage by 65.7% in the fourth quarter. Wells Fargo & Company MN now owns 13,134 shares of the company's stock valued at $81,000 after buying an additional 5,206 shares in the last quarter. BNP Paribas Financial Markets grew its holdings in shares of Lifevantage by 2,555.8% during the second quarter. BNP Paribas Financial Markets now owns 6,135 shares of the company's stock valued at $80,000 after buying an additional 5,904 shares during the last quarter. Finally, Jain Global LLC bought a new stake in shares of Lifevantage during the fourth quarter worth about $76,000. Institutional investors own 35.32% of the company's stock.
About Lifevantage
(
Get Free Report)
LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company's flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.
Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Lifevantage, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lifevantage wasn't on the list.
While Lifevantage currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
